Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from 4 more countries
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company has secured 506 marketing approvals for its oncology products across 76 countries.
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
This is the fourth facility from the company to receive this registration
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
The company also plans to register the similar range of products in the neighbouring countries.
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections
Subscribe To Our Newsletter & Stay Updated